Discover what's new.

Access the latest news, business developments, company updates, industry trends, events and more.

| By Kelley Gipson

UConn teams studying aging, mitochondria

A team of researchers at UConn are working on ways to reverse the effects of aging, as a way to mitigate the severity of a...

| By Kelley Gipson

Manchester’s Woven prepares device for U.S. sale

Woven Orthopedic Technologies, based in Manchester,  is bringing its surgical screw sleeves, in development since 2013, to the U.S. market. The FDA granted a so-called...

| By Kelley Gipson

Bristol Myers Squibb acquires MyoKardia

Bristol-Myers Squibb has successfully completed its acquisition of MyoKardia in an all cash transaction for approximately $13.1 billion. “We are excited to welcome MyoKardia colleagues...

| By Kelley Gipson

Guilford’s Homodeus ramps up for COVID home test

A nasal swab test from Guilford’s Homodeus is showing progress in trials. “So far, the clinical studies have been 100% accurate both in terms detecting positives...

| By Kelley Gipson

Intensity reports favorable data re solid tumor drug

Intensity Therapeutics has reported efficacy and safety data from the ongoing Phase 1/2 clinical study of INT230-6, the Company’s lead product candidate. “The preliminary data generated...

| By Kelley Gipson

AstraZeneca reports ‘highly effective’ vaccine

The drugmaker AstraZeneca announced on Monday that an early analysis of some of its late-stage clinical trials, conducted in the United Kingdom and Brazil, showed...

| By Kelley Gipson

Dr. Carine Boustany promoted at Boehringer Ingelheim

Dr. Carine Boustany has been named Global Head, Development Science and Head, Development Site U.S. at Boehringer Ingelheim, beginning January 1, 2021. Dr. Boustany sits on...

| By Kelley Gipson

Halda to move to Science Park in New Haven

Halda Therapeutics, a Branford-based biotech company, plans to move to New Haven after signing a lease for a 9,800 square-foot lab and office space in in...

| By Kelley Gipson

Yale expands rollout of SalivaDirect virus test

Yale University has added 13 states to the national rollout of its much-anticipated SalivaDirect COVID-19 test. Yale has now approved more than 30 independent labs...